Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:15 pm Purchase | 2025-12-31 | 13G | Adicet Bio, Inc. ACET | TANG CAPITAL MANAGEMENT, LLC | 6,158 0.100% | 6,158 (New Position) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Cybin Inc. Common Stock HELP | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -1,830,097 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -11,065,662 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Evolus, Inc. EOLS | TANG CAPITAL MANAGEMENT, LLC | 1,245,692 1.920% | -3,751,707 (-75.07%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Keros Therapeutics, Inc. KROS | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -2,418,984 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Nkarta, Inc. NKTX | TANG CAPITAL MANAGEMENT, LLC | 1,480,823 2.100% | -5,533,277 (-78.89%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Precision BioSciences, Inc. DTIL | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -673,332 (Position Closed) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | TANG CAPITAL MANAGEMENT, LLC | 1,892,200 2.400% | -1,307,800 (-40.87%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TANG CAPITAL MANAGEMENT, LLC | 1,188,624 2.800% | -1,266,173 (-51.58%) | Filing History |
| 2026-01-26 4:15 pm Purchase | 2026-01-16 | 13G | Capricor Therapeutics, Inc. CAPR | TANG CAPITAL MANAGEMENT, LLC | 3,399,900 6.600% | 3,399,900 (New Position) | Filing History |
| 2025-11-14 4:17 pm Unchanged | 2025-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:17 pm Unchanged | 2025-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 66,879 3.500% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:17 pm Unchanged | 2025-09-30 | 13G | Compass Therapeutics, Inc. CMPX | TANG CAPITAL MANAGEMENT, LLC | 17,176,510 9.990% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:17 pm Unchanged | 2025-09-30 | 13G | ESSA Pharma Inc. EPIX | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -3,158,265 (Position Closed) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | TANG CAPITAL MANAGEMENT, LLC | 66,879 3.500% | -100,000 (-59.92%) | Filing History |
| 2025-11-14 4:15 pm Purchase | 2025-09-30 | 13G | Compass Therapeutics, Inc. CMPX | TANG CAPITAL MANAGEMENT, LLC | 17,176,510 9.990% | 3,680,302 (+27.27%) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | ESSA Pharma Inc. EPIX | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -4,300,000 (Position Closed) | Filing History |
| 2025-10-29 6:30 pm Purchase | 2025-10-27 | 13G | Galapagos N.V. GLPG | TANG CAPITAL MANAGEMENT, LLC | 5,559,674 8.400% | 649,149 (+13.22%) | Filing History |
| 2025-10-24 4:16 pm Purchase | 2025-10-17 | 13G | Immunocore Holdings plc IMCR | TANG CAPITAL MANAGEMENT, LLC | 2,605,608 5.200% | 2,605,608 (New Position) | Filing History |